Assessment of potential treatments for drug-induced respiratory depression and overdose toxicity. POP: september 26, 2022 - march 25, 2023. Task order 75N95022F00002 (TO2).
Ended Awarded Last action
- Contract number
- 75N95022F00002
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $162,965
Award facts
- Opportunity
-
- Assessment of Potential Treatments to Treat Drug-induced Respiratory Depression and Overdose Toxicity Pre-Solicitation · Posted Sep 7, 2021
- Contract value 100% obligated
- $162,965.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $162,965 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $163,000 cost-plus-fixed-fee delivery order contract to Lovelace Biomedical Research Institute. The contract is for the assessment of potential treatments for drug-induced respiratory depression and overdose toxicity under Task Order 75N95022F00002 of an unspecified multiple award contract vehicle. Lovelace will conduct the assessment from September 2022 through September 2024 in Albuquerque, New Mexico. The contract aims to address the National Institute on Drug Abuse's programs focused on developing medical solutions to drug overdoses.
Quick answers
Who was awarded contract 75N95022F00002?
75N95022F00002 was awarded to Lovelace Biomedical Research Institute by National Institute on Drug Abuse (National Institutes of Health) on September 26, 2022.
How much is contract 75N95022F00002 worth?
The government has obligated $162,965 on 75N95022F00002.
Is contract 75N95022F00002 an order under another contract?
Yes. 75N95022F00002 is a delivery order under 75N95022D00019, an indefinite delivery contract.
Was contract 75N95022F00002 competed?
The extent of competition for 75N95022F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award